Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3R)-3-hydroxylauroyl-methylphosphopantetheine + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
methylphosphopantetheine + UDP-3-N-((3R)-3-hydroxylauroyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
synthetic (3R)-3-hydroxylauroyl-methylphosphopantetheine is an excellent alternative donor substrate for LiLpxA
-
-
?
(R)-3-hydroxydecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydodecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-galactosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-galactosamine
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
(R)-3-hydroxyhexadecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxyhexadecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxylauroyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-((3R)-3-hydroxylauroyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
LiLpxA is highly selective for (R)-3-hydroxylauroyl-[acyl-carrier protein] and UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
-
?
(R)-3-hydroxymyristoyl-[acyl carrier protein] + UDP-N-acetylglucosamine
[acyl-carrier protein] + UDP-3-O-((3R)-3-hydroxymyristoyl)-alpha-D-glucosamine
first step in lipid A biosynthesis
-
-
?
(R)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine
first step in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-butyrylglucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-butyrylglucosamine
-
transacylation at 8% the rate of the reaction with UDP-N-acetylglucosamine
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-propionyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-propionyl-alpha-D-glucosamine
-
transacylation at 22% the rate of the reaction with UDP-N-acetylglucosamine
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
(R,S)-3-hydroxyhexadecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxyhexadecanoyl)-N-acetyl-alpha-D-glucosamine
(R,S)-3-hydroxylauroyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxylauroyl)-N-acetyl-alpha-D-glucosamine
(R,S)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
(S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
transacylation at 7% the rate of (R)-enantiomer
-
-
?
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
decanoyl-[acyl-carrier protein] + UDP-N-acetylglucosamine
[acyl-carrier protein] + UDP-3-O-decanoyl-N-acetylglucosamine
-
-
-
-
?
myristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-myristoyl-N-acetyl-alpha-D-glucosamine
-
higher specific activity than to (R,S)-3-hydroxymyristoyl-[acyl-carrier-protein]
-
-
?
R,S-3-hydroxypalmitoyl-ACP + UDP-N-acetyl-alpha-D-glucosamine
ACP + UDP-3-O-(3-hydroxypalmitoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
R-3-hydroxydecanoyl-[acyl carrier protein] + UDP-N-acetylglucosamine
[acyl-carrier protein] + UDP-3-O-hydroxydecanoyl-N-acetylglucosamine
first step in lipid A biosynthesis
-
-
?
additional information
?
-
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydodecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydodecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
the enzyme is absolute specific for 3-hydroxylauroyl-ACP as donor substrate
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydodecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-galactosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-galactosamine
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-galactosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-galactosamine
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
?
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
specific for UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
only in vitro
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
low activity
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
essential for cell growth of gram-negative bacteria
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
involved with EC 2.4.1.182 and 2.7.1.130 in the biosynthesis of the phosphorylated glycolipid and outer membrane component, Lipid A
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
LpxA is essential for the growth of Escherichia coli, and is important in lipid A biosynthesis, overview
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
the enzyme is responsible for the first step of lipid A biosynthesis, lipid A is an integral component of the lipopolysaccharide that forms the selective and protective outer monolayer of Gram-negative bacteria, and is essential for bacterial growth and viability
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
i.e. (R)-3-hydroxymyristoyl-[acyl-carrier protein], the enzyme catalyzes the first step of lipid A biosynthesis, the transfer of the (R)-3-hydroxyacyl chain from (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] to the glucosamine 3-OH group of UDP-GlcNAc
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
substrate binding site structure with prominent hydrophilic interactions between highly conserved clusters of residues Asn198, Glu200, Arg204 and Arg205 with UDP, and Asp74, His125, His144 and Gln161 with the GlcNAc moiety, these interactions serve to bind and orient the substrate for catalysis, overview
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
substrate binding site structure with prominent hydrophilic interactions between highly conserved clusters of residues Asn198, Glu200, Arg204 and Arg205 with UDP, and Asp74, His125, His144 and Gln161 with the GlcNAc moiety, these interactions serve to bind and orientate the substrate for catalysis, overview
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
first step in lipid A biosynthesis pathway
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
i.e. (R)-3-hydroxymyristoyl-[acyl-carrier protein], the forward reaction direction is thermodynamically unfavorable, recombinant His-tagged enzyme, the activity with mutant acyl-carrier proteins is impaired, especially with mutations of the B-site of the acyl-carrier protein, recombinant wild-type and mutant ACP substrates, overview
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
main activity in crude extracts
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
i.e. 3-hydroxylauroyl-[acyl-carrier-protein], poor substrate
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxydodecanoyl)-N-acetyl-alpha-D-glucosamine
-
main activity in crude extracts
-
-
?
(R,S)-3-hydroxyhexadecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxyhexadecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxyhexadecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxyhexadecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxylauroyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxylauroyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxylauroyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxylauroyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxylauroyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxylauroyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
r
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
no substrates are UDPglucosamine, UDP-N-(R)-3-hydroxymyristoylglucosamine, ADP-N-acetylglucosamine, GDP-N-acetylglucosamine, CDP-N-acetylglucosamine, (R)-3-hydroxytetradecanoyl-CoA, or palmitoyl-CoA, myristoyl-[acyl-carrier-protein], and palmitoyl-[acyl-carrier-protein]
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
no substrates are UDPglucosamine, UDP-N-(R)-3-hydroxymyristoylglucosamine, ADP-N-acetylglucosamine, GDP-N-acetylglucosamine, CDP-N-acetylglucosamine, (R)-3-hydroxytetradecanoyl-CoA, or palmitoyl-CoA, myristoyl-[acyl-carrier-protein], and palmitoyl-[acyl-carrier-protein]
-
-
r
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
high specificity with respect to acyl-donor, equilibrium constant favors thioester acyl carrier substrate
-
-
r
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
no substrates are UDPglucosamine, UDP-N-(R)-3-hydroxymyristoylglucosamine, ADP-N-acetylglucosamine, GDP-N-acetylglucosamine, CDP-N-acetylglucosamine, (R)-3-hydroxytetradecanoyl-CoA, or palmitoyl-CoA, myristoyl-[acyl-carrier-protein], and palmitoyl-[acyl-carrier-protein]
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R,S)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
r
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
specificity for (R)-3-hydroxymyristoyl-ACP over other chain lengths in vitro
-
-
r
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
r
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
assay is optimal at 10 nM LpxA
-
-
?
additional information
?
-
substrate specificity, lipid A structure overview
-
-
?
additional information
?
-
-
substrate specificity, no activity with UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose due to lack of genes gnnA and gnnB, lipid A structure overview
-
-
?
additional information
?
-
nucleotide substrate recognition by LpxA, overview
-
-
?
additional information
?
-
-
nucleotide substrate recognition by LpxA, overview
-
-
?
additional information
?
-
-
development of a fluorescence polarization assay, detecting displacement of a fluorescently labeled peptide inhibitor based on the previously reported inhibitor peptide 920 by active site ligands, for high-throughput screening of LpxA competitve inhibitors, overview
-
-
?
additional information
?
-
-
substrate specificity, no activity with UDP-N-acetylglucosamine, lipid A structure overview
-
-
?
additional information
?
-
-
substrate specificity, no activity with UDP-N-acetylglucosamine, equally effective with 3-hydroxyacyl-ACP of different chain lengths, lipid A structure overview
-
-
?
additional information
?
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
additional information
?
-
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
additional information
?
-
LpxA displays better binding affinity with UDP-GlcNAc than with UDP-GalNAc. Binding of UDP-GlcNActo LpxA is driven by a very favorable enthalpy change(DeltaH = ?6.03 kcal/mol) with a dissociation constant of 22.62 microM. One monomer of McLpxA binds to one molecule ofUDP-GlcNAc
-
-
-
additional information
?
-
-
LpxA displays better binding affinity with UDP-GlcNAc than with UDP-GalNAc. Binding of UDP-GlcNActo LpxA is driven by a very favorable enthalpy change(DeltaH = ?6.03 kcal/mol) with a dissociation constant of 22.62 microM. One monomer of McLpxA binds to one molecule ofUDP-GlcNAc
-
-
-
additional information
?
-
LpxA displays better binding affinity with UDP-GlcNAc than with UDP-GalNAc. Binding of UDP-GlcNActo LpxA is driven by a very favorable enthalpy change(DeltaH = ?6.03 kcal/mol) with a dissociation constant of 22.62 microM. One monomer of McLpxA binds to one molecule ofUDP-GlcNAc
-
-
-
additional information
?
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-3-hydroxydodecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxydodecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
additional information
?
-
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
[acyl-carrier protein] + UDP-3-N-(3-hydroxytetradecanoyl)-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose
-
first step in lipid A biosynthesis pathway, lipid A is an unusual variant in this species containing 2,3-diamino-2,3-dideoxy-D-glucopyranose units
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
essential for cell growth of gram-negative bacteria
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
involved with EC 2.4.1.182 and 2.7.1.130 in the biosynthesis of the phosphorylated glycolipid and outer membrane component, Lipid A
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
LpxA is essential for the growth of Escherichia coli, and is important in lipid A biosynthesis, overview
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
the enzyme is responsible for the first step of lipid A biosynthesis, lipid A is an integral component of the lipopolysaccharide that forms the selective and protective outer monolayer of Gram-negative bacteria, and is essential for bacterial growth and viability
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
initial reaction in lipid A biosynthesis
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
first step in lipid A biosynthesis pathway
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
(R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
[acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
r
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
?
an (R)-3-hydroxytetradecanoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine
an [acyl-carrier protein] + UDP-3-O-(3-hydroxytetradecanoyl)-N-acetyl-alpha-D-glucosamine
-
-
-
-
r
additional information
?
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
additional information
?
-
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
additional information
?
-
the enzyme is responsible for the first step of lipid A biosynthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3aR,10aR,13aR,20aR)-2,12-dimethyldecahydro-1H,10aH-[1,4,7,10,13,16]hexaoxacyclooctadecino[11,12-c:2,3-c']dipyrrole-1,3,11,13(2H,12H,13aH)-tetrone
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
(3Z,5Z,7S,8S,9S,11Z,13E,15S,16S)-16-[(2R,3S,4R,6E,8S,9S)-3,9-dihydroxy-4,8-dimethyl-5-oxodec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
1-benzoyl-2-(1H-indol-3-ylmethyl)-4-(2-oxo-2-(1-pyrrolidinyl)ethyl)-3-piperidinol
binding energy score of 4.01. In docked pose, the pyrrolidine ring of the molecule is positioned along H120 of chain A and the indole ring is placed towards chain E. It forms hydrogen bonds with H120 (NE atom) and Q156 (OE1 atom), G139 (N backbone) from chain A and G150 (N backbone) of chain E
2-[[2-[(benzenesulfonyl)oxy]ethyl](phenyl)amino]ethyl 4-methylbenzene-1-sulfonate
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
3-((3-(((3,4-dichlorophenoxy)acetyl)amino)-15-pyridin-1-yl)methyl)benzenesulfonyl fluoride
binding energy score of 4.4. The dichlorophenoxy-acetyl-amino group occupies a position similar to that of the uridine moiety of the nucleotide substrate. The chlorine atom forms hydrophobic interactions with I147, M165 and V129 of chain E whereas the sulfur group forms pi-sulfur interaction with H120 of chain A
5-amino-4-hydroxy-3-[(E)-[8-hydroxy-6-(hydroxysulfonothioyl)-3-sulfonaphthalen-1-yl]diazenyl]naphthalene-2,7-disulfonic acid
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
7-[3-([(2S)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
DL-3-hydroxymyristic acid
-
competitive versus TAMRA peptide
erythroskyrin
binding energy score of ?4.17, spans between two subunits of LpxA interacting with Q68 (OE1 and OE2 atom), L70 (N backbone) and H120 (NE2 atom) of chain A and G196 (backbone O), K200 (NZ atom) of chain E
FITC-P920
-
i.e. FITC-(beta)SSGWMLDPIAGKWSRNH2, fluoresecent-labeled peptide
myristoyl-[acyl-carrier protein]
N-(2-hydroxyethyl)-N'-(2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecin-15-yl)urea
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
N-(2-[[(6-chloro-2H,4H-1,3-benzodioxin-8-yl)methyl]sulfanyl]phenyl)-N'-(3,4-dichlorophenyl)thiourea
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
N1-(4,4-dihydroxybutyl)-N4-(2,2-dihydroxyethyl)benzene-1,4-disulfonamide
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
P920
-
i.e. SSGWMLDPIAGKWSR
pyridoxal 5'-phosphate/sodium borohydride
-
-
RJPXD31
-
i.e. QHFMVPDINDMQ-NH2
RJPXD33
-
i.e. TNLYMLPKWDIP-NH2, a peptide identified from a phage-bound random peptide library screen uing Escherichia oli strain XL-1 Blue, binds to UDP-3-O-(R-3-hydroxyacyl)GlcN N-acyltransferase, LpxD, and UDP-N-acetylglucosamine acyltransferase, LpxA. RJPXD33 binds to LpxA in a competitive fashion with P920
TAMRA peptide
-
ability of the TAMRA-peptide to inhibit the catalytic activity
-
tris[2-[2-(2-hydroxyethoxy)ethoxy]ethyl] phosphate
compound identified using a complex-based pharmacophore model. Compound shows selective inhibition properties with essential residues in the pocket. The compound complies with the Lipinski rule showing no toxicity and drug likeness properties
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine
-
competitive versus TAMRA peptide
UDP-N-acetylglucosamine
-
competitive versus TAMRA peptide
myristoyl-[acyl-carrier protein]
-
-
myristoyl-[acyl-carrier protein]
-
-
peptide 920
a pentadecapeptide
-
peptide 920
pentadecapeptide NH2-SSGWMLDPIAGKWSR-COOH, the enzyme binds peptide 920 with three peptides, each of which adopts a beta-hairpin conformation, bound per LpxA trimer, the peptides are located at the interfaces of adjacent subunits in the vicinity of the three active sites, each peptide interacts with residues from both adjacent subunits, noncovalent interaction and binding structure, overview
-
peptide 920
-
i.e. pentadecapeptide 920, with C-terminus WMLDPIAGKWSR, competitive versus peptide inhibitors derived from its own C-terminal sequence
-
additional information
-
no inhibition by N-ethylmaleimide, UDP-2,3-diacyl-N-glucosamine, lipid X, lipid IVA, 3-deoxy-D-mannooctulosonate, octyl-beta-D-glucoside
-
additional information
-
no inhibition by N-ethylmaleimide, UDP-2,3-diacyl-N-glucosamine, lipid X, lipid IVA, 3-deoxy-D-mannooctulosonate, octyl-beta-D-glucoside
-
additional information
-
no inhibition by N-ethylmaleimide, UDP-2,3-diacyl-N-glucosamine, lipid X, lipid IVA, 3-deoxy-D-mannooctulosonate, octyl-beta-D-glucoside
-
additional information
-
measurement of binding of fluorescein-labeled peptide to acyltransferase by measuring the changes in fluorescence polarization, KD values, overview. No inhibition of LpxA by SENNFMLPLLPL-NH2, i.e. peptide RJPXD34
-
additional information
-
development of a fluorescence polarization assay, detecting displacement of a fluorescently labeled peptide inhibitor, based on inhibitor peptide 920 C-terminal 12 residues WMLDPIAGKWSR, by active site ligands, for high-throughput screening of LpxA competitve inhibitors, overview. Abilities of several ligands to compete with TAMRA peptide for binding to Escherichia coli LpxA. Acyl carrier protein does not significantly affect the inhibitory potencies
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
G189S
Escherichia coli strain SM101 is deficient in LpxA activity due to a G189S inactivating mutation. Enzymatic activity is restored when the mutant strain is transformed with a wild-type bearing plasmid is inactive
G52L/R58L
residue tolerance in the beta-helical domain: mutation is tolerated
G52V/R58V
residue tolerance in the beta-helical domain: mutation is tolerated
G52W/R58W
residue tolerance in the beta-helical domain: mutation is tolerated
G57P/N51P
residue tolerance in the beta-helical domain: mutation is not tolerated
H122A
-
lower specific activity than wild-type
H122N
-
lower specific activity than wild-type
H125N
-
lower specific activity than wild-type
H144A
-
lower specific activity than wild-type
H144N
-
lower specific activity than wild-type
H160A
-
lower specific activity than wild-type
H160F
-
lower specific activity than wild-type
H53I/D59I
residue tolerance in the beta-helical domain: mutation is tolerated
H53V/D59V
residue tolerance in the beta-helical domain: mutation is tolerated
I20R
mutation in the hydrophobic residue in the beta-helical core located in rung 2: LpxA is active
I2R
mutation in the hydrophobic residue in the beta-helical core located in rung 1: LpxA is active
I38R
mutation in the hydrophobic residue in the beta-helical core located in rung 3: LpxA is partially active
I56A
mutation in the hydrophobic core of the beta-helical domain: LpxA activity is not significantly affected compared to wild-type
I56D/I62D
residue tolerance in the beta-helical domain: mutation is not tolerated
I56E/I62E
residue tolerance in the beta-helical domain: mutation is not tolerated
I56G
mutation in the hydrophobic core of the beta-helical domain: LpxA activity is decreased compared to wild-type
I56G/I62G
residue tolerance in the beta-helical domain: mutation is tolerated
I56H/I62H
residue tolerance in the beta-helical domain: mutation is not tolerated
I56K/I62K
residue tolerance in the beta-helical domain: mutation is not tolerated
I56N
mutation in the hydrophobic core of the beta-helical domain: LpxA activity is decreased compared to wild-type
I56N/I62N
residue tolerance in the beta-helical domain: mutation is tolerated
I56P/I62P
residue tolerance in the beta-helical domain: mutation is not tolerated
I56Q
mutation in the hydrophobic core of the beta-helical domain: LpxA activity is decreased compared to wild-type
I56Q/I62Q
residue tolerance in the beta-helical domain: mutation is tolerated
I56R/I62R
residue tolerance in the beta-helical domain: mutation is not tolerated
I56S/I62S
residue tolerance in the beta-helical domain: mutation is tolerated
I56W/I62W
residue tolerance in the beta-helical domain: mutation is not tolerated
I56Y/I62Y
residue tolerance in the beta-helical domain: mutation is not tolerated
K55D/E61D
residue tolerance in the beta-helical domain: mutation is tolerated
K55P/E61P
residue tolerance in the beta-helical domain: mutation is not tolerated
K76A
-
lower specific activity than wild-type
K76R
-
lower specific activity than wild-type
P10A/P28A/P34A/P183A
proline mutation at the turn region of the beta-helical domain: mutant shows lower activity compared to wild-type
P28A/P34A
proline mutation at the turn region of the beta-helical domain: mutant shows greater activity than the P10A/P28A/P34A/P183A mutant
T54D/N60D
residue tolerance in the beta-helical domain: mutation is not tolerated
T54E/N60E
residue tolerance in the beta-helical domain: mutation is not tolerated
T54G/N60G
residue tolerance in the beta-helical domain: mutation is tolerated
T54H/N60H
residue tolerance in the beta-helical domain: mutation is not tolerated
T54K/N60K
residue tolerance in the beta-helical domain: mutation is not tolerated
T54M/N60M
residue tolerance in the beta-helical domain: mutation is tolerated
T54P/N60P
residue tolerance in the beta-helical domain: mutation is not tolerated
T54Q/N60Q
residue tolerance in the beta-helical domain: mutation is tolerated
T54R/N60R
residue tolerance in the beta-helical domain: mutation is not tolerated
T54W/N60W
residue tolerance in the beta-helical domain: mutation is not tolerated
T54Y/N60Y
residue tolerance in the beta-helical domain: mutation is not tolerated
V111R
mutation in the hydrophobic residue in the beta-helical core located in rung 6: LpxA is inactive
V129R
mutation in the hydrophobic residue in the beta-helical core located in rung 7: LpxA is inactive
Y66F/Y77F/Y219F/Y223F/Y243H
all but one tyrosine residues are mutated. Mutant shows growth similar to wild-type after introduction into Escherichia coli strain SM101 bearing a defective LpxA gene (G189S), and under novobiocin supplementation
H125A
-
lower specific activity than wild-type
H125A
H125 is an important residue at the active site its mutation eliminates activity. Mutant shows significant growth reduction after introduction into Escherichia coli strain SM101 bearing a defective LpxA gene (G189S), and under novobiocin supplementation
I56R
mutation in the hydrophobic core of the beta-helical domain: LpxA activity is completely abolished compared to wild-type
I56R
mutation in the hydrophobic residue in the beta-helical core located in rung 4: LpxA is inactive
I86R
mutation in the hydrophobic residue in the beta-helical core located in rung 5: LpxA is inactive
I86R
residue is located in the fifth rung of the beta-helical domain in the hydrophobic core of a beta helix, mutant is improperly folded, destabilized and its enzymatic activity is decreased. Mutant shows significant growth reduction after introduction into Escherichia coli strain SM101 bearing a defective LpxA gene (G189S), and under novobiocin supplementation
additional information
Arabidopsis thaliana lpxA complements an Escherichia coli mutant lacking the chromosomal lpxA and promotes the synthesis of lipid A in vivo similar to the lipid A produced in the presence of Escherichia coli lpxA
additional information
-
Arabidopsis thaliana lpxA complements an Escherichia coli mutant lacking the chromosomal lpxA and promotes the synthesis of lipid A in vivo similar to the lipid A produced in the presence of Escherichia coli lpxA
additional information
-
heterologous expression of Acidithiobacillus ferrooxidans' genes lpxA, gnnA, and gnnB results in occurence of UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose utilizing activity in Escherichia coli cells with defective lpxA gene in vivo
additional information
a recombinant prion protein-LpxA protein is generated, in which a PrP fragment that is thought to be essential for the conformational conversion is incorporated into the beta-helical domain of LpxA. Partial Lpxa enzymatic activity is observed, suggesting that the beta-helical structure may be able to accommodate a portion of the prion protein sequence and, as a corollary, that a prion protein fragment may adopt left-handed parallel beta helix (LbetaH) architecture
additional information
-
a recombinant prion protein-LpxA protein is generated, in which a PrP fragment that is thought to be essential for the conformational conversion is incorporated into the beta-helical domain of LpxA. Partial Lpxa enzymatic activity is observed, suggesting that the beta-helical structure may be able to accommodate a portion of the prion protein sequence and, as a corollary, that a prion protein fragment may adopt left-handed parallel beta helix (LbetaH) architecture
additional information
construction and characterization of an isogenic Moraxella catarrhalis lpxA mutant in strain O35E, which is viable despite the complete loss of cell surface lipooligosaccharides, the mutant strain shows significantly decreased toxicity in the Limulus amebocyte lysate assay, reduced resistance to normal human serum, reduced adherence to human epithelial cells, and enhanced clearance in lungs and nasopharynx in a mouse aerosol challenge model, phenotype, overview, the mutant elicits high levels of antibodies with bactericidal activity and provides protection against a challenge with the wild-type strain, thus the null LOS mutant is attenuated and may be a potential vaccine candidate against Moraxella catarrhalis
additional information
-
construction and characterization of an isogenic Moraxella catarrhalis lpxA mutant in strain O35E, which is viable despite the complete loss of cell surface lipooligosaccharides, the mutant strain shows significantly decreased toxicity in the Limulus amebocyte lysate assay, reduced resistance to normal human serum, reduced adherence to human epithelial cells, and enhanced clearance in lungs and nasopharynx in a mouse aerosol challenge model, phenotype, overview, the mutant elicits high levels of antibodies with bactericidal activity and provides protection against a challenge with the wild-type strain, thus the null LOS mutant is attenuated and may be a potential vaccine candidate against Moraxella catarrhalis
additional information
-
construction and characterization of an isogenic Moraxella catarrhalis lpxA mutant in strain O35E, which is viable despite the complete loss of cell surface lipooligosaccharides, the mutant strain shows significantly decreased toxicity in the Limulus amebocyte lysate assay, reduced resistance to normal human serum, reduced adherence to human epithelial cells, and enhanced clearance in lungs and nasopharynx in a mouse aerosol challenge model, phenotype, overview, the mutant elicits high levels of antibodies with bactericidal activity and provides protection against a challenge with the wild-type strain, thus the null LOS mutant is attenuated and may be a potential vaccine candidate against Moraxella catarrhalis
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Anderson, M.S.; Bulawa, C.E.; Raetz, C.R.
The biosynthesis of gram-negative endotoxin. Formation of lipid A precursors from UDP-GlcNAc in extracts of Escherichia coli
J. Biol. Chem.
260
15536-15541
1985
Escherichia coli, Escherichia coli JB1104
brenda
Anderson, M.S.; Raetz, C.R.
UDP-N-acetylglucosamine 3-O-acyltransferase from Escherichia coli
Methods Enzymol.
209
449-454
1992
Escherichia coli
brenda
Anderson, M.S.; Raetz, C.R.
Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine
J. Biol. Chem.
262
5159-5169
1987
Escherichia coli, Escherichia coli W3106, Escherichia coli JB1104
brenda
Anderson, M.S.; Bull, H.G.; Galloway, S.M.; Kelly, T.M.; Mohan, S.; Radika, K.; Raetz, C.R.
UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable
J. Biol. Chem.
268
19858-19865
1993
Escherichia coli
brenda
Williamson, J.M.; Anderson, M.S.; Raetz, C.R.
Acyl-acyl carrier protein specificity of UDP-GlcNAc acyltransferases from gram-negative bacteria: relationship to lipid A structure
J. Bacteriol.
173
3591-3596
1991
Acinetobacter calcoaceticus, Klebsiella aerogenes, Citrobacter freundii, Escherichia coli, Klebsiella oxytoca, Proteus mirabilis, Pseudomonas aeruginosa, Cereibacter sphaeroides, Serratia marcescens, Escherichia coli SM105, Escherichia coli JB1104
brenda
Vaara, M.
Eight bacterial proteins, including UDP-N-acetylglucosamine acyltransferase (LpxA) and three other transferases of Escherichia coli, consist of a six-residue periodicity theme
FEMS Microbiol. Lett.
97
249-254
1992
Escherichia coli
-
brenda
Raetz, C.R.H.; Roderick, S.L.
A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acyltransferase
Science
270
997-1000
1995
Escherichia coli
brenda
Sorensen, P.G.; Lutkenhaus, J.; Young, K.; Eveland, S.S.; Anderson, M.S.; Raetz, C.R.H.
Regulation of UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase in Escherichia coli. The second enzymic step of lipid A biosynthesis
J. Biol. Chem.
271
25898-25905
1996
Escherichia coli, Escherichia coli SM105
brenda
Wyckoff, T.J.O.; Raetz, C.R.H.
The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase. Chemical modification and site-directed mutagenesis
J. Biol. Chem.
274
27047-27055
1999
Escherichia coli
brenda
Odegaard, T.J.; Kaltashov, I.A.; Cotter, R.J.; Steeghs, L.; Van Der Ley, P.; Khan, S.; Maskell, D.J.; Raetz, C.R.H.
Shortened hydroxyacyl chains on lipid A of Escherichia coli cells expressing a foreign UDP-N-acetylglucosamine O-acyltransferase
J. Biol. Chem.
272
19688-19696
1997
Escherichia coli, Neisseria meningitidis
brenda
Wyckoff, T.J.O.; Lin, S.; Cotter, R.J.; Dotson, G.D.; Raetz, C.R.H.
Hydrocarbon rulers in UDP-N-acetylglucosamine acyltransferases
J. Biol. Chem.
273
32369-32372
1998
Escherichia coli, Pseudomonas aeruginosa
brenda
Dotson, G.D.; Kaltashov, I.A.; Cotter, R.J.; Raetz, C.R.H.
Expression cloning of a Pseudomonas gene encoding a hydroxydecanoyl-acyl carrier protein-dependent UDP-GlcNAc acyltransferase
J. Bacteriol.
180
330-337
1998
Pseudomonas aeruginosa
brenda
Sweet, C.R.; Preston, A.; Toland, E.; Ramirez, S.M.; Cotter, R.J.; Maskell, D.J.; Raetz, C.R.H.
Relaxed acyl chain specificity of Bordetella UDP-N-acetylglucosamine acyltransferases
J. Biol. Chem.
277
18281-18290
2002
Bordetella bronchiseptica, Bordetella parapertussis, Bordetella pertussis
brenda
Sweet, C.R.; Lin, S.; Cotter, R.J.; Raetz, C.R.H.
A Chlamydia trachomatis UDP-N-acetylglucosamine acyltransferase selective for myristoyl-acyl carrier protein. Expression in Escherichia coli and formation of hybrid lipid A species
J. Biol. Chem.
276
19565-19574
2001
Chlamydia trachomatis
brenda
Lee, B.I.; Lee, J.Y.; Moon, J.; Han, B.W.; Suh, S.W.
Crystallization and preliminary x-ray crystallographic analysis of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori
Acta Crystallogr. Sect. D
58
864-866
2002
Helicobacter pylori
brenda
Sweet, C.R.; Williams, A.H.; Karbarz, M.J.; Werts, C.; Kalb, S.R.; Cotter, R.J.; Raetz, C.R.
Enzymatic synthesis of lipid A molecules with four amide-linked acyl chains. LpxA acyltransferases selective for an analog of UDP-N-acetylglucosamine in which an amine replaces the 3"-hydroxyl group
J. Biol. Chem.
279
25411-25419
2004
Escherichia coli, Leptospira interrogans, Mesorhizobium loti, Acidithiobacillus ferrooxidans (Q6QHI7)
brenda
Lee, B.I.; Suh, S.W.
Crystal structure of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori
Proteins
53
772-774
2003
Helicobacter pylori
brenda
Peng, D.; Hong, W.; Choudhury, B.P.; Carlson, R.W.; Gu, X.X.
Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate
Infect. Immun.
73
7569-7577
2005
Moraxella catarrhalis (Q3BDJ0), Moraxella catarrhalis, Moraxella catarrhalis O35E (Q3BDJ0)
brenda
Gong, H.; Murphy, A.; McMaster, C.R.; Byers, D.M.
Neutralization of acidic residues in helix II stabilizes the folded conformation of acyl carrier protein and variably alters its function with different enzymes
J. Biol. Chem.
282
4494-4503
2007
Vibrio harveyi
brenda
Ulaganathan, V.; Buetow, L.; Hunter, W.N.
Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis
J. Mol. Biol.
369
305-312
2007
Escherichia coli (P0A722), Escherichia coli
brenda
Williams, A.H.; Immormino, R.M.; Gewirth, D.T.; Raetz, C.R.
Structure of UDP-N-acetylglucosamine acyltransferase with a bound antibacterial pentadecapeptide
Proc. Natl. Acad. Sci. USA
103
10877-10882
2006
Escherichia coli (P0A722), Escherichia coli
brenda
Williams, A.H.; Raetz, C.R.
Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase
Proc. Natl. Acad. Sci. USA
104
13543-13550
2007
Escherichia coli (P0A722), Escherichia coli
brenda
Gong, H.; Murphy, P.W.; Langille, G.M.; Minielly, S.J.; Murphy, A.; McMaster, C.R.; Byers, D.M.
Tryptophan fluorescence reveals induced folding of Vibrio harveyi acyl carrier protein upon interaction with partner enzymes
Biochim. Biophys. Acta
1784
1835-1843
2008
Escherichia coli
brenda
Robins, L.I.; Williams, A.H.; Raetz, C.R.
Structural basis for the sugar nucleotide and acyl-chain selectivity of Leptospira interrogans LpxA
Biochemistry
48
6191-6201
2009
Leptospira interrogans (Q8EZA6), Leptospira interrogans
brenda
Choi, J.H.; May, B.C.; Govaerts, C.; Cohen, F.E.
Site-directed mutagenesis demonstrates the plasticity of the beta helix: implications for the structure of the misfolded prion protein
Structure
17
1014-1023
2009
Escherichia coli (P0A722), Escherichia coli
brenda
Jenkins, R.J.; Dotson, G.D.
Dual targeting antibacterial peptide inhibitor of early lipid a biosynthesis
ACS Chem. Biol.
7
1170-1177
2012
Escherichia coli
brenda
Jenkins, R.J.; Dotson, G.D.
A continuous fluorescent enzyme assay for early steps of lipid A biosynthesis
Anal. Biochem.
425
21-27
2012
Escherichia coli
brenda
Joo, S.H.; Chung, H.S.; Raetz, C.R.; Garrett, T.A.
Activity and crystal structure of Arabidopsis thaliana UDP-N-acetylglucosamine acyltransferase
Biochemistry
51
4322-4330
2012
Arabidopsis thaliana (Q9SU91), Arabidopsis thaliana
brenda
Das, A.; Mukhopadhyay, C.
LpxA: a natural nanotube
Biopolymers
93
845-853
2010
Escherichia coli
brenda
Shapiro, A.B.; Ross, P.L.; Gao, N.; Livchak, S.; Kern, G.; Yang, W.; Andrews, B.; Thresher, J.
A high-throughput-compatible fluorescence anisotropy-based assay for competitive inhibitors of Escherichia coli UDP-N-acetylglucosamine acyltransferase (LpxA)
J. Biomol. Screen.
18
341-347
2013
Escherichia coli
brenda
Li, C.; Guan, Z.; Liu, D.; Raetz, C.R.
Pathway for lipid A biosynthesis in Arabidopsis thaliana resembling that of Escherichia coli
Proc. Natl. Acad. Sci. USA
108
11387-11392
2011
Arabidopsis thaliana (Q9SU91)
brenda
Ngo, A.; Fong, K.T.; Cox, D.L.; Chen, X.; Fisher, A.J.
Structures of Bacteroides fragilis uridine 5-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA)
Acta Crystallogr. Sect. D
71
1068-1076
2015
Bacteroides fragilis (Q5LH16), Bacteroides fragilis DSM 2151 (Q5LH16)
brenda
Smith, E.W.; Zhang, X.; Behzadi, C.; Andrews, L.D.; Cohen, F.; Chen, Y.
Structures of Pseudomonas aeruginosa LpxA reveal the basis for its substrate selectivity
Biochemistry
54
5937-5948
2015
Pseudomonas aeruginosa (A6V1E4), Pseudomonas aeruginosa, Pseudomonas aeruginosa PA7 (A6V1E4)
brenda
Jenkins, R.J.; Heslip, K.A.; Meagher, J.L.; Stuckey, J.A.; Dotson, G.D.
Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis
J. Biol. Chem.
289
15527-15535
2014
Escherichia coli (P0A722), Escherichia coli
brenda
Joo, S.H.; Chung, H.S.
Crystal structure and activity of Francisella novicida UDP-N-acetylglucosamine acyltransferase
Biochem. Biophys. Res. Commun.
478
1223-1229
2016
Francisella tularensis subsp. novicida
brenda
Bhaskar, B.; Babu, T.; Rammohan, A.; Zheng, G.; Zyryanov, G.; Gu, W.
Structure-based virtual screening of Pseudomonas aeruginosa Lpxa inhibitors using pharmacophore-based approach
Biomolecules
10
266
2020
Pseudomonas aeruginosa (A6V1E4), Pseudomonas aeruginosa PA7 (A6V1E4)
brenda
Pratap, S.; Kesari, P.; Yadav, R.; Dev, A.; Narwal, M.; Kumar, P.
Acyl chain preference and inhibitor identification of Moraxella catarrhalis LpxA Insight through crystal structure and computational studies
Int. J. Biol. Macromol.
96
759-765
2017
Moraxella catarrhalis (D5VAW8), Moraxella catarrhalis, Moraxella catarrhalis BBH18 (D5VAW8)
brenda
Kim, S.; Yoon, H.; Ryu, S.
New virulence factor CSK29544_02616 as LpxA binding partner in Cronobacter sakazakii
Sci. Rep.
8
835
2018
Cronobacter sakazakii
brenda
Dangkulwanich, M.; Raetz, C.R.H.; Williams, A.H.
Structure guided design of an antibacterial peptide that targets UDP-N-acetylglucosamine acyltransferase
Sci. Rep.
9
3947
2019
Escherichia coli (P0A722), Escherichia coli
brenda